Ducas Robin, Ariyarajah Vignendra
Section of Cardiology Dept. of Cardiac Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Division of Cardiology, The Brooklyn Hospital Center, Weill Cornell Medical College, Brooklyn, New York.
J Atr Fibrillation. 2013 Feb 12;5(5):535. doi: 10.4022/jafib.535. eCollection 2013 Feb-Mar.
Atrial fibrillation (AF) and left ventricular dysfunction (LVD) are increasingly common clinical problems, affecting millions of people worldwide. It is well established that the presence of AF portends a poor prognosis in the setting of both ischemic and non-ischemic LVD, and frequently results in worsening clinical status. Many clinical studies and trials have attempted to address treatment options and efficacy; despite this treatment for AF in LVD is still controversial.
心房颤动(AF)和左心室功能障碍(LVD)是日益常见的临床问题,影响着全球数百万人。众所周知,AF的存在预示着在缺血性和非缺血性LVD情况下预后不良,并经常导致临床状况恶化。许多临床研究和试验试图探讨治疗方案和疗效;尽管如此,LVD中AF的治疗仍存在争议。